Translational pain research: Lessons from genetics and genomics

Science Translational Medicine

Volumn 6, Issue 249, 2014, Pages

  Dib Hajj, Sulayman D ^a,b   Waxman, Stephen G ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PURINERGIC P2X7 RECEPTOR; SODIUM CHANNEL NAV1.7;

ALLODYNIA; CHRONIC PAIN; EXOME; GAIN OF FUNCTION MUTATION; GENE MAPPING; GENE SEQUENCE; GENE TARGETING; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC MODEL; GENETIC SCREENING; GENETIC VARIABILITY; GENOMICS; HAPLOTYPE; HUMAN; MONOGENIC DISORDER; MUTATIONAL ANALYSIS; NONHUMAN; PAIN; PSYCHOGENIC PAIN; RARE DISEASE; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSLATIONAL RESEARCH; ANIMAL; GENETICS; MOLECULARLY TARGETED THERAPY;

ANIMALS; EXOME; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; MOLECULAR TARGETED THERAPY; PAIN; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84907413060     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3007017     Document Type: Review

References (112)

1. A. Tsang, M. Von Korff, S. Lee, J. Alonso, E. Karam, M. C. Angermeyer, G. L. Borges, E. J. Bromet, K. Demytteneare, G. de Girolamo, R. de Graaf, O. Gureje, J. P. Lepine, J. M. Haro, D. Levinson, M. A. Oakley Browne, J. Posada-Villa, S. Seedat, M. Watanabe, Common chronic pain conditions in developed and developing countries: Gender and age differences and comorbidity with depression-anxiety disorders. J. Pain 9, 883-891 (2008).
2. Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education, Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research (National Academies Press, Washington, DC, 2011).
3. A. I. Basbaum, D. M. Bautista, G. Scherrer, D. Julius, Cellular and molecular mechanisms of pain. Cell 139, 267-284 (2009).
4. M. Costigan, J. Scholz, C. J. Woolf, Neuropathic pain: A maladaptive response of the nervous system to damage. Annu. Rev. Neurosci. 32, 1-32 (2009).
5. S. D. Dib-Hajj, T. R. Cummins, J. A. Black, S. G. Waxman, Sodium channels in normal and pathological pain. Annu. Rev. Neurosci. 33, 325-347 (2010).
6. D. Borsook, R. Hargreaves, C. Bountra, F. Porreca, Lost but making progress - Where will new analgesic drugs come from? Sci. Transl. Med. 6, 249sr3 (2014).
7. M. I. McCarthy, G. R. Abecasis, L. R. Cardon, D. B. Goldstein, J. Little, J. P. Ioannidis, J. N. Hirschhorn, Genome-wide association studies for complex traits: Consensus, uncertainty and challenges. Nat. Rev. Genet. 9, 356-369 (2008).
8. L. Diatchenko, R. B. Fillingim, S. B. Smith, W. Maixner, The phenotypic and genetic signatures of common musculoskeletal pain conditions. Nat. Rev. Rheumatol. 9, 340-350 (2013).
9. J. S. Mogil, Pain genetics: Past, present and future. Trends Genet. 28, 258-266 (2012).
10. J. S. Mogil, Animal models of pain: Progress and challenges. Nat. Rev. Neurosci. 10, 283-294 (2009).
11. Pain Genes Database; http://paingeneticslab.ca.
12. C. J. Bult, J. T. Eppig, J. A. Blake, J. A. Kadin, J. E. Richardson; Mouse Genome Database Group, The mouse genome database: Genotypes, phenotypes, and models of human disease. Nucleic Acids Res. 41, D885-D891 (2013).
13. M. Devor, A. Gilad, M. Arbilly, B. Yakir, P. Raber, A. Pisanté, A. Darvasi, pain1: A neuropathic pain QTL on mouse chromosome 15 in a C3HxC58 backcross. Pain 116, 289-293 (2005).
14. J. Nissenbaum, M. Devor, Z. Seltzer, M. Gebauer, M. Michaelis, M. Tal, R. Dorfman, M. Abitbul-Yarkoni, Y. Lu, T. Elahipanah, S. delCanho, A. Minert, K. Fried, A. K. Persson, H. Shpigler, E. Shabo, B. Yakir, A. Pisanté, A. Darvasi, Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2. Genome Res. 20, 1180-1190 (2010).
15. 2+-channel γ subunit. Nat. Genet. 19, 340-347 (1998).
16. R. E. Sorge, T. Trang, R. Dorfman, S. B. Smith, S. Beggs, J. Ritchie, J. S. Austin, D. V. Zaykin, H. Vander Meulen, M. Costigan, T. A. Herbert, M. Yarkoni-Abitbul, D. Tichauer, J. Livneh, E. Gershon, M. Zheng, K. Tan, S. L. John, G. D. Slade, J. Jordan, C. J. Woolf, G. Peltz, W. Maixner, L. Diatchenko, Z. Seltzer, M. W. Salter, J. S. Mogil, Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Nat. Med. 18, 595-599 (2012).
17. R. Sluyter, L. Stokes, Significance of P2X7 receptor variants to human health and disease. Recent Pat. DNA Gene Seq. 5, 41-54 (2011).
18. M. F. Jarvis, The neural-glial purinergic receptor ensemble in chronic pain states. Trends Neurosci. 33, 48-57 (2010).
19. Z. Ali, B. Laurijssens, T. Ostenfeld, S. McHugh, A. Stylianou, P. Scott-Stevens, L. Hosking, O. Dewit, J. C. Richardson, C. Chen, Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects. Br. J. Clin. Pharmacol. 75, 197-207 (2013).
20. T. C. Stock, B. J. Bloom, N. Wei, S. Ishaq, W. Park, X. Wang, P. Gupta, C. A. Mebus, Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate. J. Rheumatol. 39, 720-727 (2012).
21. G. G. Neely, A. Hess, M. Costigan, A. C. Keene, S. Goulas, M. Langeslag, R. S. Griffin, I. Belfer, F. Dai, S. B. Smith, L. Diatchenko, V. Gupta, C. P. Xia, S. Amann, S. Kreitz, C. Heindl-Erdmann, S. Wolz, C. V. Ly, S. Arora, R. Sarangi, D. Dan, M. Novatchkova, M. Rosenzweig, D. G. Gibson, D. Truong, D. Schramek, T. Zoranovic, S. J. Cronin, B. Angjeli, K. Brune, G. Dietzl, W. Maixner, A. Meixner, W. Thomas, J. A. Pospisilik, M. Alenius, M. Kress, S. Subramaniam, P. A. Garrity, H. J. Bellen, C. J. Woolf, J. M. Penninger, A genome-wide Drosophila screen for heat nociception identifies α2δ3 as an evolutionarily conserved pain gene. Cell 143, 628-638 (2010).
22. G. Dietzl, D. Chen, F. Schnorrer, K. C. Su, Y. Barinova, M. Fellner, B. Gasser, K. Kinsey, S. Oppel, S. Scheiblauer, A. Couto, V. Marra, K. Keleman, B. J. Dickson, A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature 448, 151-156 (2007).
23. A. Davies, J. Hendrich, A. T. Van Minh, J. Wratten, L. Douglas, A. C. Dolphin, Functional biology of the α2δ subunits of voltage-gated calcium channels. Trends Pharmacol. Sci. 28, 220-228 (2007).
24. I. Tegeder, M. Costigan, R. S. Griffin, A. Abele, I. Belfer, H. Schmidt, C. Ehnert, J. Nejim, C. Marian, J. Scholz, T. Wu, A. Allchorne, L. Diatchenko, A. M. Binshtok, D. Goldman, J. Adolph, S. Sama, S. J. Atlas, W. A. Carlezon, A. Parsegian, J. Lötsch, R. B. Fillingim, W. Maixner, G. Geisslinger, M. B. Max, C. J. Woolf, GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat. Med. 12, 1269-1277 (2006).
25. B. Thony, G. Auerbach, N. Blau, Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem. J. 347 (Pt. 1), 1-16 (2000).
26. S. J. Kim, W. I. Lee, Y. S. Lee, D. H. Kim, J. W. Chang, S. W. Kim, H. Lee, Effective relief of neuropathic pain by adeno-associated virus-mediated expression of a small hairpin RNA against GTP cyclohydrolase 1. Mol. Pain 5, 67 (2009).
27. M. Costigan, A. Latremoliere, C. J. Woolf, Analgesia by inhibiting tetrahydrobiopterin synthesis. Curr. Opin. Pharmacol. 12, 92-99 (2012).
28. I. Tegeder, J. Adolph, H. Schmidt, C. J. Woolf, G. Geisslinger, J. Lötsch, Reduced hyperalgesia in homozygous carriers of a GTP cyclohydrolase 1 haplotype. Eur. J. Pain 12, 1069-1077 (2008).
29. A. Doehring, R. Freynhagen, N. Griessinger, M. Zimmermann, R. Sittl, H. Nv, G. Geisslinger, J. Lötsch, Cross-sectional assessment of the consequences of a GTP cyclohydrolase 1 haplotype for specialized tertiary outpatient pain care. Clin. J. Pain 25, 781-785 (2009).
30. D. H. Kim, F. Dai, I. Belfer, R. J. Banco, J. F. Martha, H. Tighiouart, S. G. Tromanhauser, L. G. Jenis, D. J. Hunter, C. E. Schwartz, Polymorphic variation of the guanosine triphosphate cyclohydrolase 1 gene predicts outcome in patients undergoing surgical treatment for lumbar degenerative disc disease. Spine 35, 1909-1914 (2010).
31. J. Lötsch, P. Klepstad, A. Doehring, O. Dale, A GTP cyclohydrolase 1 genetic variant delays cancer pain. Pain 148, 103-106 (2010).
32. H. Kim, R. A. Dionne, Lack of influence of GTP cyclohydrolase gene (GCH1) variations on pain sensitivity in humans. Mol. Pain 3, 6 (2007).
33. M. Lazarev, J. Lamb, M. M. Barmada, F. Dai, M. A. Anderson, M. B. Max, D. C. Whitcomb, Does the pain-protective GTP cyclohydrolase haplotype significantly alter the pattern or severity of pain in humans with chronic pancreatitis? Mol. Pain 4, 58 (2008).
34. U. Heddini, N. Bohm-Starke, A. Grönbladh, F. Nyberg, K. W. Nilsson, U. Johannesson, GCH1-polymorphism and pain sensitivity among women with provoked vestibulodynia. Mol. Pain 8, 68 (2012).
35. L. Hendry, Z. Lombard, A. Wadley, P. Kamerman, KCNS1, but not GCH1, is associated with pain intensity in a black Southern African population with HIV-associated sensory neuropathy: A genetic association study. J. Acquir. Immune Defic. Syndr. 63, 27-30 (2013).
36. L. Diatchenko, A. G. Nackley, I. E. Tchivileva, S. A. Shabalina, W. Maixner, Genetic architecture of human pain perception. Trends Genet. 23, 605-613 (2007).
37. L. Diatchenko, G. D. Slade, A. G. Nackley, K. Bhalang, A. Sigurdsson, I. Belfer, D. Goldman, K. Xu, S. A. Shabalina, D. Shagin, M. B. Max, S. S. Makarov, W. Maixner, Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum. Mol. Genet. 14, 135-143 (2005).
38. A. G. Nackley, S. A. Shabalina, I. E. Tchivileva, K. Satterfield, O. Korchynskyi, S. S. Makarov, W. Maixner, L. Diatchenko, Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314, 1930-1933 (2006).
39. E. E. Young, W. R. Lariviere, I. Belfer, Genetic basis of pain variability: Recent advances. J. Med. Genet. 49, 1-9 (2012).
40. K. J. Oedegaard, T. A. Greenwood, S. Johansson, K. K. Jacobsen, A. Halmoy, O. B. Fasmer, H. S. Akiskal; Bipolar Genome Study (BiGS), J. Haavik, J. R. Kelsoe, A genome-wide association study of bipolar disorder and comorbid migraine. Genes Brain Behav. 9, 673-680 (2010).
41. V. Anttila, H. Stefansson, M. Kallela, U. Todt, G. M. Terwindt, M. S. Calafato, D. R. Nyholt, A. S. Dimas, T. Freilinger, B. Müller-Myhsok, V. Artto, M. Inouye, K. Alakurtti, M. A. Kaunisto, E. Hämäläinen, B. de Vries, A. H. Stam, C. M. Weller, A. Heinze, K. Heinze-Kuhn, I. Goebel, G. Borck, H. Göbel, S. Steinberg, C. Wolf, A. Björnsson, G. Gudmundsson, M. Kirchmann, A. Hauge, T. Werge, J. Schoenen, J. G. Eriksson, K. Hagen, L. Stovner, H. E. Wichmann, T. Meitinger, M. Alexander, S. Moebus, S. Schreiber, Y. S. Aulchenko, M. M. Breteler, A. G. Uitterlinden, A. Hofman, C. M. van Duijn, P. Tikka-Kleemola, S. Vepsäläinen, S. Lucae, F. Tozzi, P. Muglia, J. Barrett, J. Kaprio, M. Färkkilä, L. Peltonen, K. Stefansson, J. A. Zwart, M. D. Ferrari, J. Olesen, M. Daly, M. Wessman, A. M. van den Maagdenberg, M. Dichgans, C. Kubisch, E. T. Dermitzakis, R. R. Frants, A. Palotie; International Headache Genetics Consortium, Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat. Genet. 42, 869-873 (2010).
42. D. I. Chasman, M. Schürks, V. Anttila, B. de Vries, U. Schminke, L. J. Launer, G. M. Terwindt, A.M. van den Maagdenberg, K. Fendrich, H. Völzke, F. Ernst, L. R. Griffiths, J. E. Buring, M. Kallela, T. Freilinger, C. Kubisch, P. M. Ridker, A. Palotie, M. D. Ferrari, W. Hoffmann, R. Y. Zee, T. Kurth, Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat. Genet. 43, 695-698 (2011).
43. M. J. Peters, L. Broer, H. L. Willemen, G. Eiriksdottir, L. J. Hocking, K. L. Holliday, M. A. Horan, I.Meulenbelt, T. Neogi, M. Popham, C.O. Schmidt, A. Soni, A. M. Valdes, N. Amin, E. M. Dennison, N. Eijkelkamp, T. B. Harris, D. J. Hart, A. Hofman, F. J. Huygen, K. A. Jameson, G. T. Jones, L. J. Launer, H. J. Kerkhof, M. de Kruijf, J. McBeth, M. Kloppenburg, W. E. Ollier, B. Oostra, A. Payton, F. Rivadeneira, B. H. Smith, A. V. Smith, L. Stolk, A. Teumer, W. Thomson, A. G. Uitterlinden, K. Wang, S. H. van Wingerden, N. K. Arden, C. Cooper, D. Felson, V. Gudnason, G. J. Macfarlane, N. Pendleton, P. E. Slagboom, T. D. Spector, H. Völzke, A. Kavelaars, C. M. van Duijn, F. M. Williams, J. B. van Meurs, Genome-wide association study meta-analysis of chronic widespread pain: Evidence for involvement of the 5p15.2 region. Ann. Rheum. Dis. 72, 427-436 (2013).
44. M. J. Bamshad, S. B. Ng, A. W. Bigham, H. K. Tabor, M. J. Emond, D. A. Nickerson, J. Shendure, Exome sequencing as a tool for Mendelian disease gene discovery. Nat. Rev. Genet. 12, 745-755 (2011).
45. F. M. Williams, S. Scollen, D. Cao, Y. Memari, C. L. Hyde, B. Zhang, B. Sidders, D. Ziemek, Y. Shi, J. Harris, I. Harrow, B. Dougherty, A. Malarstig, R. McEwen, J. C. Stephens, K. Patel, C. Menni, S. Y. Shin, D. Hodgkiss, G. Surdulescu, W. He, X. Jin, S. B. McMahon, N. Soranzo, S. John, J. Wang, T. D. Spector, Genes contributing to pain sensitivity in the normal population: An exome sequencing study. PLOS Genet. 8, e1003095 (2012).
46. J. Marques-Lopes, M. Pinto, D. Pinho, M. Morato, D. Patinha, A. Albino-Teixeira, I. Tavares, Microinjection of angiotensin II in the caudal ventrolateral medulla induces hyperalgesia. Neuroscience 158, 1301-1310 (2009).
47. U. Anand, P. Facer, Y. Yiangou, M. Sinisi, M. Fox, T. McCarthy, C. Bountra, Y. E. Korchev, P. Anand, Angiotensin II type 2 receptor (AT2R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons. Eur. J. Pain 17, 1012-1026 (2013).
48. J. D. Roberts, M. H. Gollob, Distinguishing pathogenic mutations from innocuous rare variants in gene discovery for Brugada syndrome. Can. J. Cardiol. 28, 160-161 (2012).
49. v1.7 sodium channel: From molecule to man. Nat. Rev. Neurosci. 14, 49-62 (2013).
50. B. Kremeyer, F. Lopera, J. J. Cox, A. Momin, F. Rugiero, S. Marsh, C. G. Woods, N. G. Jones, K. J. Paterson, F. R. Fricker, A. Villegas, N. Acosta, N. G. Pineda-Trujillo, J. D. Ramírez, J. Zea, M. W. Burley, G. Bedoya, D. L. Bennett, J. N. Wood, A. Ruiz-Linares, A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. Neuron 66, 671-680 (2010).
51. W. A. Catterall, A. L. Goldin, S. G. Waxman, International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol. Rev. 57, 397-409 (2005).
52. R. H. Dworkin, A. B. O'Connor, J. Audette, R. Baron, G. K. Gourlay, M. L. Haanpää, J. L. Kent, E. J. Krane, A. A. Lebel, R. M. Levy, S. C. Mackey, J. Mayer, C. Miaskowski, S. N. Raja, A. S. Rice, K. E. Schmader, B. Stacey, S. Stanos, R. D. Treede, D. C. Turk, G. A. Walco, C. D.Wells, Recommendations for the pharmacological management of neuropathic pain: An overview and literature update. Mayo Clin. Proc. 85, S3-S14 (2010).
53. P. Gerner, G. R. Strichartz, Sensory and motor complications of local anesthetics. Muscle Nerve 37, 421-425 (2008).
54. J. J. Toledo-Aral, B. L. Moss, Z. J. He, A. G. Koszowski, T. Whisenand, S. R. Levinson, J. J. Wolf, I. Silos-Santiago, S. Halegoua, G. Mandel, Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc. Natl. Acad. Sci. U.S.A. 94, 1527-1532 (1997).
55. +channel α-subunit protein. J. Physiol. 546, 565-576 (2003).
56. T. R. Cummins, J. R. Howe, S. G. Waxman, Slow closed-state inactivation: A novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel. J. Neurosci. 18, 9607-9619 (1998).
57. v1.7 sodium channels in mouse spinal sensory neurons. J. Physiol. 551, 741-750 (2003).
58. S. G. Waxman, Channel, neuronal and clinical function in sodium channelopathies: From genotype to phenotype. Nat. Neurosci. 10, 405-409 (2007).
59. J. A. Black, N. Frézel, S. D. Dib-Hajj, S. G. Waxman, Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn. Mol. Pain 8, 82 (2012).
60. M. S. Minett, M. A. Nassar, A. K. Clark, G. Passmore, A. H. Dickenson, F. Wang, M. Malcangio, J. N. Wood, Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons. Nat. Commun. 3, 791 (2012).
61. W. H. Finley, J. R. Lindsey Jr., J. D. Fine, G. A. Dixon, M. K. Burbank, Autosomal dominant erythromelalgia. Am. J. Med. Genet. 42, 310-315 (1992).
62. Y. Yang, Y. Wang, S. Li, Z. Xu, H. Li, L. Ma, J. Fan, D. Bu, B. Liu, Z. Fan, G. Wu, J. Jin, B. Ding, X. Zhu, Y. Shen, Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J. Med. Genet. 41, 171-174 (2004).
63. v1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain 128, 1847-1854 (2005).
64. v1.7 sodium channels in a painful inherited neuropathy. J. Neurosci. 24, 8232-8236 (2004).
65. v1.7 channel is disrupted by the erythromelalgia-associated F1449V mutation. J. Biol. Chem. 283, 24118-24127 (2008).
66. Y. Yang, M. Estacion, S. D. Dib-Hajj, S. G. Waxman, Molecular architecture of a sodium channel S6 helix: Radial tuning of the voltage-gated sodium channel 1.7 activation gate. J. Biol. Chem. 288, 13741-13747 (2013).
67. C. R. Fertleman, M. D. Baker, K. A. Parker, S. Moffatt, F. V. Elmslie, B. Abrahamsen, J. Ostman, N. Klugbauer, J. N. Wood, R. M. Gardiner, M. Rees, SCN9A mutations in paroxysmal extreme pain disorder: Allelic variants underlie distinct channel defects and phenotypes. Neuron 52, 767-774 (2006).
68. v1.7 renders DRG neurons hyperexcitable. Mol. Pain 4, 37 (2008).
69. J. J. Cox, F. Reimann, A. K. Nicholas, G. Thornton, E. Roberts, K. Springell, G. Karbani, H. Jafri, J. Mannan, Y. Raashid, L. Al-Gazali, H. Hamamy, E. M. Valente, S. Gorman, R. Williams, D. P. McHale, J. N. Wood, F. M. Gribble, C. G. Woods, An SCN9A channelopathy causes congenital inability to experience pain. Nature 444, 894-898 (2006).
70. A. M. Rush, S. D. Dib-Hajj, S. Liu, T. R. Cummins, J. A. Black, S. G. Waxman, A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc. Natl. Acad. Sci. U.S.A. 103, 8245-8250 (2006).
71. X. Y. Zhang, J. Wen, W. Yang, C. Wang, L. Gao, L. H. Zheng, T. Wang, K. Ran, Y. Li, X. Li, M. Xu, J. Luo, S. Feng, X. Ma, H. Ma, Z. Chai, Z. Zhou, J. Yao, X. Zhang, J. Y. Liu, Gain-of-function mutations in SCN11A cause familial episodic pain. Am. J. Hum. Genet. 93, 957-966 (2013).
72. E. Leipold, L. Liebmann, G. C. Korenke, T. Heinrich, S. Giesselmann, J. Baets, M. Ebbinghaus, R.O. Goral, T. Stödberg, J. C. Hennings, M. Bergmann, J. Altmüller, H. Thiele, A. Wetzel, P. Nürnberg, V. Timmerman, P. De Jonghe, R. Blum, H. G. Schaible, J. Weis, S. H. Heinemann, C. A. Hübner, I. Kurth, A de novo gain-of-function mutation in SCN11A causes loss of pain perception. Nat. Genet. 45, 1399-1404 (2013).
73. +current regulates excitability in mouse and rat small diameter sensory neurones. J. Physiol. 548, 373-382 (2003).
74. v1.9. J. Physiol. 586, 1077-1087 (2008).
75. v1.7. Mol. Pain 7, 92 (2011).
76. v1.7 mutations in idiopathic small fiber neuropathy. Ann. Neurol. 71, 26-39 (2012).
77. v1.7-related small fiber neuropathy: Impaired slow-inactivation and DRG neuron hyperexcitability. Neurology 78, 1635-1643 (2012).
78. v1.7 mutation. Brain 135, 345-358 (2012).
79. C. Han, J. G. Hoeijmakers, S. Liu, M. M. Gerrits, R. H. te Morsche, G. Lauria, S. D. Dib-Hajj, J. P. Drenth, C. G. Faber, I. S. Merkies, S. G. Waxman, Functional profiles of SCN9A variants in dorsal root ganglion neurons and superior cervical ganglion neurons correlate with autonomic symptoms in small fibre neuropathy. Brain 135, 2613-2628 (2012).
80. M. Estacion, T. P. Harty, J. S. Choi, L. Tyrrell, S. D. Dib-Hajj, S. G. Waxman, A sodium channel gene SCN9A polymorphism that increases nociceptor excitability. Ann. Neurol. 66, 862-866 (2009).
81. F. Reimann, J. J. Cox, I. Belfer, L. Diatchenko, D. V. Zaykin, D. P. McHale, J. P. Drenth, F. Dai, J. Wheeler, F. Sanders, L. Wood, T. X. Wu, J. Karppinen, L. Nikolajsen, M. Männikkö, M. B. Max, C. Kiselycznyk, M. Poddar, R. H. Te Morsche, S. Smith, D. Gibson, A. Kelempisioti, W. Maixner, F. M. Gribble, C. G. Woods, Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc. Natl. Acad. Sci. U.S.A. 107, 5148-5153 (2010).
82. G. Vargas-Alarcon, E. Alvarez-Leon, J. M. Fragoso, A. Vargas, A. Martinez, M. Vallejo, M. Martinez-Lavin, A SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgia. BMC Musculoskelet. Disord. 13, 23 (2012).
83. J. A. Black, L. Nikolajsen, K. Kroner, T. S. Jensen, S. G. Waxman, Multiple sodium channel isoforms and mitogen-activated protein kinases are present in painful human neuromas. Ann. Neurol. 64, 644-653 (2008).
84. R. Amir, M. Devor, Ongoing activity in neuroma afferents bearing retrograde sprouts. Brain Res. 630, 283-288 (1993).
85. J. Serra, H. Bostock, R. Solà, J. Aleu, E. García, B. Cokic, X. Navarro, C. Quiles, Microneurographic identification of spontaneous activity in C-nociceptors in neuropathic pain states in humans and rats. Pain 153, 42-55 (2012).
86. v1.7 and alters its gating properties. J. Neurosci. 30, 1637-1647 (2010).
87. J. A. Black, S. Liu, M. Tanaka, T. R. Cummins, S. G. Waxman, Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain. Pain 108, 237-247 (2004).
88. S. Hong, T. J. Morrow, P. E. Paulson, L. L. Isom, J. W. Wiley, Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat. J. Biol. Chem. 279, 29341-29350 (2004).
89. v1.7) levels through activation of protein kinase C in painful diabetic neuropathy. J. Neurosci. 28, 6652-6658 (2008).
90. A. N. Akopian, L. Sivilotti, J. N. Wood, A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 379, 257-262 (1996).
91. +current in the action potentials of nociceptive sensory neurons. J. Neurosci. 22, 10277-10290 (2002).
92. v1.8 sodium channels to action potential electrogenesis in DRG neurons. J. Neurophysiol. 86, 629-640 (2001).
93. A. M. Binshtok, H. Wang, K. Zimmermann, F. Amaya, D. Vardeh, L. Shi, G. J. Brenner, R. R. Ji, B. P. Bean, C. J. Woolf, T. A. Samad, Nociceptors are interleukin-1β sensors. J. Neurosci. 28, 14062-14073 (2008).
94. v1.8 by p38 mitogen-activated protein kinase increases current density in dorsal root ganglion neurons. J. Neurosci. 28, 3190-3201 (2008).
95. X. Jin, R. W. Gereau, Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-α. J. Neurosci. 26, 246-255 (2006).
96. B. Abrahamsen, J. Zhao, C. O. Asante, C. M. Cendan, S. Marsh, J. P. Martinez-Barbera, M. A. Nassar, A. H. Dickenson, J. N. Wood, The cell and molecular basis of mechanical, cold, and inflammatory pain. Science 321, 702-705 (2008).
97. A. N. Akopian, V. Souslova, S. England, K. Okuse, N. Ogata, J. Ure, A. Smith, B. J. Kerr, S. B. McMahon, S. Boyce, R. Hill, L. C. Stanfa, A. H. Dickenson, J. N. Wood, The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat. Neurosci. 2, 541-548 (1999).
98. v1.8 is essential for pain at low temperatures. Nature 447, 855-858 (2007).
99. v1.8 mutations in painful neuropathy. Proc. Natl. Acad. Sci. U.S.A. 109, 19444-19449 (2012).
100. v1.7 mutation showing use-dependent current fall-off. Exp. Neurol. 216, 383-389 (2009).
101. v1.7 mutation producing carbamazepine-responsive erythromelalgia. Ann. Neurol. 65, 733-741 (2009).
102. M. Mantegazza, G. Curia, G. Biagini, D. S. Ragsdale, M. Avoli, Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders. Lancet Neurol. 9, 413-424 (2010).
103. v1.7 mutant channel. Nat. Commun. 3, 1186 (2012).
104. v1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker. Pain 153, 80-85 (2012).
105. v1.7 voltage-dependent sodium channels, International Association for the Study of Pain 14th World Congress on Pain, Milan, Italy, 2012.
106. v1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc. Natl. Acad. Sci. U.S.A. 104, 8520-8525 (2007).
107. J. Seok, H. S. Warren, A. G. Cuenca, M. N. Mindrinos, H. V. Baker, W. Xu, D. R. Richards, G. P. McDonald-Smith, H. Gao, L. Hennessy, C. C. Finnerty, C. M. López, S. Honari, E. E. Moore, J. P. Minei, J. Cuschieri, P. E. Bankey, J. L. Johnson, J. Sperry, A. B. Nathens, T. R. Billiar, M. A. West, M. G. Jeschke, M. B. Klein, R. L. Gamelli, N. S. Gibran, B. H. Brownstein, C. Miller-Graziano, S. E. Calvano, P. H. Mason, J. P. Cobb, L. G. Rahme, S. F. Lowry, R. V. Maier, L. L. Moldawer, D. N. Herndon, R. W. Davis, W. Xiao, R. G. Tompkins; Inflammation and Host Response to Injury, Large Scale Collaborative Research Program, Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. U.S.A. 110, 3507-3512 (2013).
108. J. M. Dawes, M. Calvo, J. R. Perkins, K. J. Paterson, H. Kiesewetter, C. Hobbs, T. K. Kaan, C. Orengo, D. L. Bennett, S. B. McMahon, CXCL5 mediates UVB irradiation-induced pain. Sci. Transl. Med. 3, 90ra60 (2011).
109. S. M. Chambers, Y. Qi, Y. Mica, G. Lee, X. J. Zhang, L. Niu, J. Bilsland, L. Cao, E. Stevens, P. Whiting, S. H. Shi, L. Studer, Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. Nat. Biotechnol. 30, 715-720 (2012).
110. K. R. Veeramah, J. E. O'Brien, M. H. Meisler, X. Cheng, S. D. Dib-Hajj, S. G. Waxman, D. Talwar, S. Girirajan, E. E. Eichler, L. L. Restifo, R. P. Erickson, M. F. Hammer, De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. Am. J. Hum. Genet. 90, 502-510 (2012).
111. A. Mortazavi, B. A. Williams, K. McCue, L. Schaeffer, B. Wold, Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5, 621-628 (2008).
112. v1.7 gene underlie congenital indifference to pain in multiple human populations. Clin. Genet. 71, 311-319 (2007).